Subasi Ersoy, Subasi Munevver Mine, Hammer Peter L, Roboz John, Anbalagan Victor, Lipkowitz Michael S
Department of Engineering Systems, Florida Institute of Technology, Melbourne, FL, United States.
Department of Mathematical Sciences, Florida Institute of Technology, Melbourne, FL, United States.
Front Med (Lausanne). 2017 Jul 19;4:97. doi: 10.3389/fmed.2017.00097. eCollection 2017.
The African American Study of Kidney Disease and Hypertension (AASK), a randomized double-blinded treatment trial, was motivated by the high rate of hypertension-related renal disease in the African-American population and the scarcity of effective therapies. This study describes a pattern-based classification approach to predict the rate of decline of kidney function using surface-enhanced laser desorption ionization/time of flight proteomic data from rapid and slow progressors classified by rate of change in glomerular filtration rate. An accurate classification model consisting of 7 out of 5,751 serum proteomic features is constructed by applying the logical analysis of data (LAD) methodology. On cross-validation by 10-folding, the model was shown to have an accuracy of 80.6 ± 0.11%, sensitivity of 78.4 ± 0.17%, and specificity of 78.5 ± 0.16%. The LAD discriminant is used to identify the patients in different risk groups. The LAD risk scores assigned to 116 AASK patients generated a receiver operating curves curve with AUC 0.899 (CI 0.845-0.953) and outperforms the risk scores assigned by proteinuria, one of the best predictors of chronic kidney disease progression.
非裔美国人肾脏疾病与高血压研究(AASK)是一项随机双盲治疗试验,开展该试验的原因是非洲裔美国人群中高血压相关肾病的高发率以及有效治疗方法的匮乏。本研究描述了一种基于模式的分类方法,该方法利用表面增强激光解吸电离/飞行时间蛋白质组学数据,对根据肾小球滤过率变化率分类的快速进展者和缓慢进展者的肾功能下降速率进行预测。通过应用数据逻辑分析(LAD)方法,构建了一个由5751个血清蛋白质组特征中的7个组成的准确分类模型。经10折交叉验证,该模型的准确率为80.6±0.11%,灵敏度为78.4±0.17%,特异性为78.5±0.16%。LAD判别法用于识别不同风险组中的患者。分配给116名AASK患者的LAD风险评分生成了一条受试者工作特征曲线,曲线下面积为0.899(95%置信区间0.845 - 0.953),优于蛋白尿所分配的风险评分,蛋白尿是慢性肾病进展的最佳预测指标之一。